Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nintedanib”

197 trials

Showing 20 of 197 results

Not applicableNo Longer AvailableNCT02230982
What this trial is testing

Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim
Testing effectiveness (Phase 2)Ended earlyNCT02902484
What this trial is testing

Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer

Who this might be right for
Cancer of Pancreas
University of Texas Southwestern Medical Center 14
Early research (Phase 1)Ended earlyNCT00979576
What this trial is testing

BIBF 1120 in Combination With Pemetrexed in Advanced Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 19
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07583589
What this trial is testing

Nintedanib With or Without Dextromethorphan in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
First Affiliated Hospital of Wenzhou Medical University 60
Testing effectiveness (Phase 2)Study completedNCT03954782
What this trial is testing

Efficacy of Nintedanib Per os as a Treatment for Epistaxis in HHT Disease.

Who this might be right for
Telangiectasia, Hereditary HemorrhagicRendu Osler Disease
Hospices Civils de Lyon 61
Testing effectiveness (Phase 2)UnknownNCT05373914
What this trial is testing

RESPIRARE - Efficacy and Safety of Cudetaxestat in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Blade Therapeutics 200
Early research (Phase 1)Study completedNCT01314105
What this trial is testing

BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Advanced Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Cancer

Who this might be right for
Ovarian NeoplasmsPeritoneal Neoplasms
Boehringer Ingelheim 19
Testing effectiveness (Phase 2)Study completedNCT02531737
What this trial is testing

Nintedanib (Vargatef®) Plus Docetaxel in Second Line of Treatment in Patients With Lung Cancer

Who this might be right for
Lung Neoplasms
University Hospital, Limoges 59
Not applicableStudy completedNCT03958071
What this trial is testing

A Study Based on Medical Records That Looks at the Characteristics of Idiopathic Pulmonary Fibrosis Patients Grouped by the Type of Medication They Are Taking

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 13,264
Testing effectiveness (Phase 2)Ended earlyNCT02389764
What this trial is testing

Nintedanib For HER2-Negative Metastatic Inflammatory Breast Cancer (MIBC)

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 10
Early research (Phase 1)Study completedNCT05262751
What this trial is testing

A Study in Healthy Men to Find the Best Formulation for Once Daily Intake of Nintedanib

Who this might be right for
Healthy
Boehringer Ingelheim 21
Early research (Phase 1)Study completedNCT03675581
What this trial is testing

Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)

Who this might be right for
Scleroderma, Systemic
Boehringer Ingelheim 17
Not applicableWithdrawnNCT05676112
What this trial is testing

Safety of Nintedanib in Real World in China

Who this might be right for
Pulmonary Fibrosis
Boehringer Ingelheim
Large-scale testing (Phase 3)Study completedNCT01619085
What this trial is testing

Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 752
Not applicableStudy completedNCT04525547
What this trial is testing

Safety and Effectiveness of Nintedanib in Korean Patients

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 70
Post-approval studies (Phase 4)Study completedNCT05799755
What this trial is testing

Myositis Interstitial Lung Disease Nintedanib Trial

Who this might be right for
Myositis Associated Interstitial Lund Disease (MA-ILD)
Rohit Aggarwal, MD 49
Early research (Phase 1)Study completedNCT02182076
What this trial is testing

Pharmacokinetics/Bioavailability of BIBF 1120 Administered to Healthy Male Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 15
Large-scale testing (Phase 3)Study completedNCT05285982
What this trial is testing

Evaluate Long-term Safety of Nintedanib in Children and Adolescents With Interstitial Lung Disease (InPedILD®-ON)

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 54
Testing effectiveness (Phase 2)Study completedNCT02308553
What this trial is testing

Efficacy and Safety of Nintedanib Combined With Paclitaxel Chemotherapy for Patients With BRAF wt Metastatic Melanoma

Who this might be right for
Cutaneous Malignant Melanoma
Prof. Dr. med. Dirk Schadendorf 33
Large-scale testing (Phase 3)Study completedNCT01335464
What this trial is testing

Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients

Who this might be right for
Pulmonary Fibrosis
Boehringer Ingelheim 515
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation